rf-fullcolor.png

 

May 31, 2012
by RAPS

South Korean Regulators Increase Online Data Transparency

South Korea's Korean Food and Drug Administration (KFDA) has announced the re-launch of its website, which now includes consolidated drug information covering all drugs manufactured in South Korea.

The website now features a sub-page, drug.kfda.go.kr, which allows for the public to "retrieve and utilize a variety of drug information," including drug safety, drug effects, drug development assistance, information on pharmaceutical excipients, drug use and more. Additional information covers whether a product is KFDA-approved or covered by Korea's health insurers.

KFDA said the website renovation was part of its "efforts to more actively promote safe and effective use of medications by enabling easier access of the public to drug related information including its side-effects, recommended dosage and special precautions."


Read more:

KFDA - Newly renovated website brings in information service on domestically produced drugs

KFDA - drug.kfda.go.kr

×

Welcome to the new RAPS Digital Experience

We have completed our migration to a new platform and are pleased to introduce the updated site.

What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.

We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.

We welcome your feedback. Please let us know how we can continue to improve your experience.